Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Genetic Screening Could Improve Breast Cancer Prevention

April 9, 2015 5:03 pm | by University of Cambridge | News | Comments

A test for a wide range of genetic risk factors could improve doctors’ ability to work out which women are at increased risk of developing breast cancer, a major study of more than 65,000 women has shown. Read more...

NIH Funds Nine Antimicrobial Resistance Diagnostics Projects

April 9, 2015 4:57 pm | by NIH | News | Comments

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded more than $11 million in first-year funding for nine research projects supporting enhanced diagnostics to rapidly detect antimicrobial-resistant bacteria. Read more..


Inovio to Lead $45M Program to Expedite Product Development for Ebola

April 9, 2015 4:43 pm | News | Comments

Inovio Pharmaceuticals, Inc. announced that the company has been selected to receive a grant from the Defense Advanced Research Projects Agency (DARPA) to lead a collaborative team to develop multiple treatment and prevention approaches against Ebola. Read more..


EU Approves Roche’s Avastin Therapy

April 9, 2015 4:25 pm | News | Comments

Roche announced that the European Commission (EU) approved Avastin (bevacizumab) in combination with standard chemotherapy (paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy) for the treatment of adult patients with persistent, recurrent or metastatic carcinoma of the cervix. Read more...


30% of Consumers Take Action After Viewing Prescription Ads: Study

April 9, 2015 12:52 pm | News | Comments

According to a new survey by, nearly 30 percent of consumers have been prompted into action by direct to consumer (DTC) advertising for an Rx (prescription) medication. Read more...


Prolong Pharmaceuticals' SCD Treatment Gets Orphan Drug Designation

April 9, 2015 12:43 pm | News | Comments

Prolong Pharmaceuticals, LLC, a biopharmaceutical company dedicated to developing products for the treatment of anemias, cancers and their debilitating comorbidities, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its flagship product Sanguinate for the treatment of Sickle Cell Disease (SCD). Read more...


Cellular Defect Linked to Diabetes

April 9, 2015 12:33 pm | by Columbia University | News | Comments

A cellular defect that can impair the body’s ability to handle high glucose levels and could point the way to a potential new treatment for diabetes has been identified by Columbia University Medical Center (CUMC) researchers. Read more..


Researchers Deliver Large Particles into Cells at High Speed

April 9, 2015 12:27 pm | by UCLA | News | Comments

A new device developed by UCLA engineers and doctors may eventually help scientists study the development of disease, enable them to capture improved images of the inside of cells and lead to other improvements in medical and biological research. Read more...


Scientists Awarded $1.2 Million to Find Cancer Drug Candidates

April 9, 2015 12:20 pm | by Scripps Research Institute | News | Comments

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded $1.2 million from the National Cancer Institute of the National Institutes of Health (NIH) to accelerate the development of drug candidates to curb one of the most important drivers of human cancer. Read more...


The First Personalized Genomic Cancer Vaccines

April 9, 2015 12:07 pm | by Cynthia Fox, Science Writer | Articles | Comments

The first personalized cancer vaccine using genomics to define targets elicits robust immune responses, says a recent Science study. Read more...


A Patch for Peanut Allergies

April 9, 2015 11:56 am | by Bevin Fletcher, Associate Editor | News | Comments

French biopharmaceutical company DBV Technologies moves closer to bringing its peanut allergy patch to market, receiving Breakthrough Therapy Designation from the U.S. Food and Drug Administration as it prepares to launch its Phase 3 trial. Read more...


Vitamin D Link with Depression in Overweight Women

April 9, 2015 8:43 am | by University of Adelaide | News | Comments

Researchers have discovered a previously unknown link between vitamin D and depression in overweight women with polycystic ovary syndrome. Read more...


Rhythm Initiates Phase 2b Clinical Trial of Relamorelin for Diabetic Gastroparesis

April 9, 2015 8:42 am | News | Comments

Actavis has an exclusive option to acquire Rhythm's wholly owned subsidiary, Rhythm Pharmaceuticals Inc., upon the completion of the Phase 2b study. Read more...


Biologists Identify Brain Tumor Weakness

April 9, 2015 8:42 am | by Anne Trafton, MIT | News | Comments

Biologists have discovered a vulnerability of brain cancer cells that could be exploited to develop more-effective drugs against brain tumors. Read more...


Easing the Pain

April 9, 2015 8:41 am | by Queen's University | News | Comments

The combination of two well-known drugs will have unprecedented effects on pain management. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.